These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 16136581

  • 1. Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study.
    Tebbi CK, Mendenhall N, London WB, Williams JL, de Alarcon PA, Chauvenet AR, Children's Oncology Group.
    Pediatr Blood Cancer; 2006 Feb; 46(2):198-202. PubMed ID: 16136581
    [Abstract] [Full Text] [Related]

  • 2. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 3. [Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study].
    Kochbati L, Fdhila F, Belaid I, Rifi H, Barsaoui S, Ben Romdhane N, Bel Hadj Ali Z, Mezlini A, Oubich F, Maalej M.
    Cancer Radiother; 2012 Oct 01; 16(7):627-32. PubMed ID: 23084987
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
    Wang WH, Li YX, Song YW, Jin J, Liu YP, Wang SL, Zhou LQ, Liu XF, Yu ZH, Han JZ.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar 01; 28(3):218-21. PubMed ID: 16875611
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L, Vásová I, Krejcí M, Navrátil M, Tomásková I, Jedlicka F, Chaloupka V, Mayer J, Vorlícek J.
    Vnitr Lek; 2006 Mar 01; 52(3):221-31. PubMed ID: 16722153
    [Abstract] [Full Text] [Related]

  • 8. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
    Eich HT, Staar S, Gossmann A, Hansemann K, Skripnitchenko R, Kocher M, Semrau R, Engert A, Josting A, Franklin J, Krug B, Diehl V, Müller RP, German Hodgkin Study Group.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1121-7. PubMed ID: 15001253
    [Abstract] [Full Text] [Related]

  • 9. Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-A/B Multicenter Randomized Trial.
    Djeridane M, Oudard S, Escoffre-Barbe M, Lacotte-Thierry L, Desablens B, Briére J, Dib M, Cassasus P, Ghandour C, Lamy T, Lejeune F, Simon M, Traullé C, Vigier M, Maisonneuve H, Briére J, Colonna P, Andrieu JM.
    Cancer; 2002 Nov 15; 95(10):2169-79. PubMed ID: 12412171
    [Abstract] [Full Text] [Related]

  • 10. [Multi-national therapy study for Hodgkin's disease in children and adolescents GPOH-DH 95. Interim report after 2 1/2 years].
    Dörffel W, Albrecht M, Lüders H, Marciniak H, Parwaresch R, Schwarze EW, Trauzeddel R, Havers W, Henze G, Janka-Schaub G, Mann G, Niemeyer C, Pötter R, Schellong G, Selle B, Treuner J, Rühl U.
    Klin Padiatr; 1998 Nov 15; 210(4):212-9. PubMed ID: 9743955
    [Abstract] [Full Text] [Related]

  • 11. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J, Macharová H, Pohanková R, Malír A, Coupek P, Konecný M, Patera J, Pecina J, Drbal J, Koukalová H, Vásová I.
    Neoplasma; 2000 Nov 15; 47(2):129-32. PubMed ID: 10985481
    [Abstract] [Full Text] [Related]

  • 12. APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial.
    Wimmer RS, Chauvenet AR, London WB, Villaluna D, de Alarcon PA, Schwartz CL.
    Pediatr Blood Cancer; 2006 Mar 15; 46(3):320-4. PubMed ID: 16200630
    [Abstract] [Full Text] [Related]

  • 13. [Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
    Balwierz W, Moryl-Bujakowska A, Depowska T, Klekawka T, Stanuch H, Matysiak M, Sopyło B, Kołakowska-Mrozowska B, Krenke K, Chybicka A, Raś M, Sońta-Jakimczyk D, Moszant A, Wachowiak J, Kaczmarek-Kanold M, Kowalczyk J, Odój T, Balcerska A, Drozyńska E, Wysocki M, Kołtan A, Krawczuk-Rybak M, Stolarska M.
    Przegl Lek; 2004 Mar 15; 61 Suppl 2():33-9. PubMed ID: 15688474
    [Abstract] [Full Text] [Related]

  • 14. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W, Moryl-Bujakowska A, Depowska T, Klekawka T, Stanuch H, Matysiak M, Sopyło B, Kołakowska-Mrozowska B, Krenke K, Chybicka A, Raś M, Sońta-Jakimczyk D, Moszant A, Wachowiak J, Kaczmarek-Kanold M, Kowalczyk J, Odój T, Balcerska A, Drozyńska E, Wysocki M, Kołtan A, Krawczuk-Rybak M, Stolarska M.
    Przegl Lek; 2004 Mar 15; 61 Suppl 2():40-4. PubMed ID: 15686044
    [Abstract] [Full Text] [Related]

  • 15. Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi.
    Gobbi PG, Broglia C, Merli F, Dell'Olio M, Stelitano C, Iannitto E, Federico M, Bertè R, Luisi D, Molica S, Cavalli C, Dezza L, Ascari E.
    Cancer; 2003 Dec 01; 98(11):2393-401. PubMed ID: 14635074
    [Abstract] [Full Text] [Related]

  • 16. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol AD, Kluin-Nelemans JC, Tirelli U, Monconduit M, Thomas J, Eghbali H, Aleman BM, Bosq J, Vovk M, Verschueren TA, Pény AM, Girinsky T, Raemaekers JM, Henry-Amar M.
    J Clin Oncol; 2006 Jul 01; 24(19):3128-35. PubMed ID: 16754934
    [Abstract] [Full Text] [Related]

  • 17. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
    Chow LM, Nathan PC, Hodgson DC, Jenkin D, Weitzman S, Grant RM, Manson D, Bross A, Doyle JJ, Danjoux C, Greenberg ML.
    J Clin Oncol; 2006 Dec 20; 24(36):5735-41. PubMed ID: 17179107
    [Abstract] [Full Text] [Related]

  • 18. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ.
    Ai Zheng; 2007 Dec 20; 26(12):1360-4. PubMed ID: 18076802
    [Abstract] [Full Text] [Related]

  • 19. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF, Kirkpatrick JP, Clough RW, Prosnitz RG, Gockerman JP, Moore JO, Prosnitz LR.
    J Clin Oncol; 2006 Feb 01; 24(4):605-11. PubMed ID: 16446333
    [Abstract] [Full Text] [Related]

  • 20. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
    Bonadonna G, Bonfante V, Viviani S, Di Russo A, Villani F, Valagussa P.
    J Clin Oncol; 2004 Jul 15; 22(14):2835-41. PubMed ID: 15199092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.